Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.
Saved in:
| Title: | Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors. |
|---|---|
| Authors: | Abu‐Khalaf, Maysa M.1, Baumgart, Megan A.2, Gettinger, Scott N.1, Doddamane, Indukala3, Tuck, David P.4, Hou, Shihe5, Chen, Nianhang5, Sullivan, Catherine1, Lezon‐Geyda, Kimberly1, Zelterman, Daniel6, Hatzis, Christos1, Deshpande, Hari1, Digiovanna, Michael P.1, Azodi, Masoud7, Schwartz, Peter E.7, Harris, Lyndsay N.8 |
| Source: | Cancer (0008543X). Jun2015, Vol. 121 Issue 11, p1817-1826. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 0008543X |
|---|---|
| DOI: | 10.1002/cncr.29254 |
